Enumeral Biomedical Receives $2,016,250 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e5ef4c0-5f04-4988-bc48-371dc6f63256 - Date
5/7/2014 - Company Name
Enumeral Biomedical - Mailing Address
1450 Broadway 24th Floor New York, NY 10018 USA - Company Description
Enumeral Biomedical Corp. engages in the discovery and development of native human monoclonal antibodies for use in the diagnosis and treatment of infectious, autoimmune, and inflammatory diseases, and cancers. - Website
http://www.enumeral.com - Transaction Type
Venture Equity - Transaction Amount
$2,016,250 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
